Charles Patrick France

Affiliations: 
Pharmacology University of Texas Health Science Center at San Antonio, San Antonio, TX, United States 
Area:
Behavioral pharmacology
Google:
"Charles France"
Mean distance: 15.11 (cluster 19)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Flynn SM, France CP. (2021) Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone. Drug and Alcohol Dependence. 221: 108599
Minervini V, Tye CB, Ghodrati S, et al. (2021) Effects of remifentanil/histamine mixtures in rats responding under a choice procedure. Behavioural Pharmacology
France CP, Ahern G, Averick S, et al. (2020) Countermeasures for preventing and treating opioid overdose. Clinical Pharmacology and Therapeutics
Mada S, Gerak LR, Soyer A, et al. (2020) Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist. Psychopharmacology
Minervini V, Disney A, Husbands SM, et al. (2020) Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys. Psychopharmacology
Maguire DR, France CP. (2020) Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures. Drug and Alcohol Dependence. 212: 108043
Maguire DR, Gerak LR, Sanchez JJ, et al. (2020) Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Minervini V, France CP. (2020) Effects of opioid/cannabinoid mixtures on impulsivity and memory in rhesus monkeys. Behavioural Pharmacology. 31: 233-248
Maguire DR, Gerak LR, Cami-Kobeci G, et al. (2019) OREX-1019: a novel treatment for opioid use disorder and relapse prevention. The Journal of Pharmacology and Experimental Therapeutics
Maguire DR, Minervini V, Dodda V, et al. (2019) Impact of order of fixed-ratio presentation on demand for self-administered remifentanil in male rats. Behavioural Pharmacology
See more...